Chrysalis Pharma AG – Trademark Portfolio

Entity Type: 03

Chrysalis Pharma AG holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EPANOVA. The owner is based in Sarnen 1.

Grundacher 5

Sarnen 1 6061 , CH

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EPANOVA
EPANOVA
Registered 2019
EPANOVA
EPANOVA
Cancelled 2010
OMEFAS
OMEFAS
Abandoned 2010
EPANOVA
EPANOVA
Cancelled 2010
OMEFAS
OMEFAS
Cancelled 2003
EPANOVA
EPANOVA
Cancelled 2002

Trademark Classifications

Chrysalis Pharma AG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Chrysalis Pharma AG have?

Chrysalis Pharma AG has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 4 cancelled.

What trademark classes does Chrysalis Pharma AG file in?

Chrysalis Pharma AG files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Chrysalis Pharma AG's most well-known trademarks?

Chrysalis Pharma AG's registered trademark portfolio includes well-known marks such as EPANOVA. These are among 1 currently registered trademark in the portfolio.

What is Chrysalis Pharma AG's trademark registration success rate?

Chrysalis Pharma AG has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.